EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
We are delighted to announce EORTC’s participation at the ESTRO Congress 2024 taking place from 3 to 7 May 2024 in Glasgow, UK. This year’s theme is Radiation Oncology: Bridging the Care Gap.
Save the date for the ESTRO-EORTC joint session on innovations in re-irradiation clinical trial design on Saturday 4 May 2024, from 08:45 to 10:00 AM.
In addition to the joint session, we are proud to showcase five abstracts on the topic of radiation oncology: three oral presentations and two digital posters. For a detailed overview, please consult the table below.
ESTRO-EORTC Joint Session
| Session | Scheduled on |
|---|---|
| ESTRO-EORTC – Innovations in re-irradiation clinical trial design Session Type: Interdisciplinary Session code: 1080 |
Saturday 04 May 08:45 – 10:00 GMT+1 Hall 2 |
EORTC Abstracts
| Abstract | Scheduled on |
|---|---|
| Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas among the European Organisation for Research and Treatment of Cancer (EORTC) Khaled Elsayad, Germany Session Type: Proffered Papers |
Saturday 04 May 10:30 – 11:30 GMT+1 Clyde |
| Interim results of the prospective RTQA procedures for HALT (CRUK/16/020, EORTC 1702-LCG-ROG) Daniel Portik, EORTC HQ Session Type: Proffered Papers |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 3 |
| Early Quality-of-Life after metastases-directed SBRT – results of the ESTRO & EORTC OligoCare cohort* Daniela Greto, Italy Session Type: Proffered paper |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 2 |
| Head-to-head comparison for breast RT planning: knowledge-based planning vs. deep learning solution Daniel Portik, EORTC HQ |
Digital Poster |
| A Trials within Cohorts comparing 1 fraction vs multiple-fraction SBRT in oligometastatic cancer* Piet Ost, Belgium |
Digital Poster |
*The Oligocare project is part of the E²-RADIatE platform. The E²-RADIatE platform and Oligocare project are supported by Walgreens Boots Alliance. OligoCare is also supported by Stiftung Bruckner.
Related News
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
